These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30478412)

  • 21. Leishmania (viannia) panamensis-induced cutaneous leishmaniasis in susceptible and resistant mouse strains.
    Goto H; Rojas JI; Sporrong L; De Carreira P; Sánchez C; Orn A
    Rev Inst Med Trop Sao Paulo; 1995; 37(6):475-81. PubMed ID: 8731258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tilting the balance between RNA interference and replication eradicates Leishmania RNA virus 1 and mitigates the inflammatory response.
    Brettmann EA; Shaik JS; Zangger H; Lye LF; Kuhlmann FM; Akopyants NS; Oschwald DM; Owens KL; Hickerson SM; Ronet C; Fasel N; Beverley SM
    Proc Natl Acad Sci U S A; 2016 Oct; 113(43):11998-12005. PubMed ID: 27790981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity, geographic distribution, and pathogenicity of serodemes of Leishmania viannia in Colombia.
    Saravia NG; Weigle K; Navas C; Segura I; Valderrama L; Valencia AZ; Escorcia B; McMahon-Pratt D
    Am J Trop Med Hyg; 2002 Jun; 66(6):738-44. PubMed ID: 12224583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World.
    Salay G; Dorta ML; Santos NM; Mortara RA; Brodskyn C; Oliveira CI; Barbiéri CL; Rodrigues MM
    Clin Vaccine Immunol; 2007 Sep; 14(9):1173-81. PubMed ID: 17626159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraspecies differences in natural susceptibility to amphotericine B of clinical isolates of Leishmania subgenus Viannia.
    Franco-Muñoz C; Manjarrés-Estremor M; Ovalle-Bracho C
    PLoS One; 2018; 13(4):e0196247. PubMed ID: 29698432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reproductive strategies and population structure in Leishmania: substantial amount of sex in Leishmania Viannia guyanensis.
    Rougeron V; Bañuls AL; Carme B; Simon S; Couppié P; Nacher M; Hide M; De Meeûs T
    Mol Ecol; 2011 Aug; 20(15):3116-27. PubMed ID: 21722225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of Colombian isolates of Leishmania (Viannia) panamensis, Le. (V.) guyanensis and Le. (V.) braziliensis in the sandfly Lutzomyia intermedia (Lutz & Neiva, 1912) under experimental conditions.
    Rangel EF; Travi BL; Barbosa AF; Montoya J
    Mem Inst Oswaldo Cruz; 1993; 88(4):513-5. PubMed ID: 8139462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of minicircle classes in Leishmania (Viannia) species.
    Brewster S; Barker DC
    Trans R Soc Trop Med Hyg; 2002 Apr; 96 Suppl 1():S55-63. PubMed ID: 12055852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiologic, genetic, and clinical associations among phenotypically distinct populations of Leishmania (Viannia) in Colombia.
    Saravia NG; Segura I; Holguin AF; Santrich C; Valderrama L; Ocampo C
    Am J Trop Med Hyg; 1998 Jul; 59(1):86-94. PubMed ID: 9684634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution and etiology of leishmaniasis in Colombia.
    Corredor A; Kreutzer RD; Tesh RB; Boshell J; Palau MT; Caceres E; Duque S; Pelaez D; Rodriguez G; Nichols S
    Am J Trop Med Hyg; 1990 Mar; 42(3):206-14. PubMed ID: 2316790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In silico characterization of multiple genes encoding the GP63 virulence protein from Leishmania braziliensis: identification of sources of variation and putative roles in immune evasion.
    Castro Neto AL; Brito ANALM; Rezende AM; Magalhães FB; de Melo Neto OP
    BMC Genomics; 2019 Feb; 20(1):118. PubMed ID: 30732584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The genome of Leishmania panamensis: insights into genomics of the L. (Viannia) subgenus.
    Llanes A; Restrepo CM; Del Vecchio G; Anguizola FJ; Lleonart R
    Sci Rep; 2015 Feb; 5():8550. PubMed ID: 25707621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiation of Leishmania (Viannia) panamensis and Leishmania (V.) guyanensis using BccI for hsp70 PCR-RFLP.
    Montalvo Alvarez AM; Nodarse JF; Goodridge IM; Fidalgo LM; Marin M; Van Der Auwera G; Dujardin JC; Bernal ID; Muskus C
    Trans R Soc Trop Med Hyg; 2010 May; 104(5):364-7. PubMed ID: 20227738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calmodulin Polymerase Chain Reaction-Restriction Fragment Length Polymorphism for Leishmania Identification and Typing.
    Miranda A; Samudio F; González K; Saldaña A; Brandão A; Calzada JE
    Am J Trop Med Hyg; 2016 Aug; 95(2):383-7. PubMed ID: 27352873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local Delivery of the Toll-Like Receptor 9 Ligand CpG Downregulates Host Immune and Inflammatory Responses, Ameliorating Established Leishmania (Viannia) panamensis Chronic Infection.
    Ehrlich AK; Fernández OL; Rodriguez-Pinto D; Castilho TM; Corral Caridad MJ; Goldsmith-Pestana K; Saravia NG; McMahon-Pratt D
    Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28052994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential Gene Expression and Infection Profiles of Cutaneous and Mucosal Leishmania braziliensis Isolates from the Same Patient.
    Alves-Ferreira EV; Toledo JS; De Oliveira AH; Ferreira TR; Ruy PC; Pinzan CF; Santos RF; Boaventura V; Rojo D; López-Gonzálvez Á; Rosa JC; Barbas C; Barral-Netto M; Barral A; Cruz AK
    PLoS Negl Trop Dis; 2015; 9(9):e0004018. PubMed ID: 26366580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of drug resistance related genes as candidate markers for treatment outcome prediction of cutaneous leishmaniasis in Brazil.
    Torres DC; Ribeiro-Alves M; Romero GA; Dávila AM; Cupolillo E
    Acta Trop; 2013 May; 126(2):132-41. PubMed ID: 23416123
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Coughlan S; Taylor AS; Feane E; Sanders M; Schonian G; Cotton JA; Downing T
    R Soc Open Sci; 2018 Apr; 5(4):172212. PubMed ID: 29765675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucosal disease caused by Leishmania braziliensis guyanensis.
    Santrich C; Segura I; Arias AL; Saravia NG
    Am J Trop Med Hyg; 1990 Jan; 42(1):51-5. PubMed ID: 2301705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucosal leishmaniasis due to Leishmania (Viannia) panamensis in Colombia: clinical characteristics.
    Osorio LE; Castillo CM; Ochoa MT
    Am J Trop Med Hyg; 1998 Jul; 59(1):49-52. PubMed ID: 9684627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.